| 2-METHYL-4-OXO-1,4-DIHYDRO-QUINOLINE-8-CARBOXYLIC ACID |
硼酸系列 |
384364-07-2 |
| PF 04995274 |
PF 04995274 |
2170558-28-6 |
| BMS-1001 |
BMS-1001 |
2113650-03-4 |
| HM-30181 mesylate monohydrate |
化合物HM-30181 MESYLATE MONOHYDRATE |
2097125-58-9 |
| Benzeneacetonitrile, α-(diphenylmethylene)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)- |
2-(4-PINACOLATOBORONPHENYL)-3,3-DIPHENYLACRYLONITRILE |
288105-07-7 |
| dBRD9 |
DBRD9 |
2170679-45-3 |
| Imidodicarbonimidic diamide, N-[2-(2-methylphenyl)ethyl]- |
Imidodicarbonimidic diamide, N-[2-(2-methylphenyl)ethyl]- |
1544871-16-0 |
| (S)-2-Hydroxy-2’-[(R)-hydroxy(4-pyridyl)methyl]-[1,1’-binaphthalene] |
(S)-2-羟基-2'-[(R)-羟基(4-吡啶基)甲基]-[1,1'-联萘] |
1498319-66-6 |
| TWS 119 |
TWS-119 |
1507095-58-0 |
| 2-(bromomethyl)-5-methyloxazole |
2-(bromomethyl)-5-methyloxazole |
1394021-83-0 |
| Atezolizumab |
阿特珠单抗 |
1380723-44-3 |
| 4-AMINO-5-CHLORO-2-METHOXY-BENZOIC ACID 2-(DIETHYLAMINO)ETHYL ESTER HYDROCHLORIDE |
4-AMINO-5-CHLORO-2-METHOXY-BENZOIC ACID 2-(DIETHYLAMINO)ETHYL ESTER HYDROCHLORIDE |
1197334-02-3 |
| 1,4-Butanediol, 2-[2-(2-amino-9H-purin-9-yl)ethyl]-, 1,4-diacetate |
泛昔洛韦杂质 |
174155-69-2 |
| H2N-PEG3-CH2COOtBu |
H2N-PEG3-CH2COOtBu |
189808-70-6 |
| CALPAIN INHIBITOR XII |
CALPAIN INHIBITOR XII |
181769-57-3 |
| Vilazodone Hydrochloride |
盐酸维拉唑酮 |
163521-08-2 |
| N-(3-Oxotetradecanoyl)-L-homoserine lactone |
N-(3-氧代十四烷酰基)-L-高丝氨酸内酯 |
177158-19-9 |
| Everolimus |
依维莫司 |
159351-69-6 |
| Infliximab |
英夫利昔单抗 |
170277-31-3 |
| 2-(3-bromothiophen-2-yl)ethanol |
2-(3-溴噻吩-2-基)乙烷-1-醇 |
141811-49-6 |
QQ
微信
